COHR showed solid operational momentum with revenue growing 19% alongside meaningful increases in R&D investment and capital expenditures, though current liabilities expanded notably.
The company appears to be in a growth investment phase, with substantial increases in R&D spending and capital expenditures suggesting confidence in future opportunities. However, the 34% increase in current liabilities warrants monitoring to ensure it reflects operational growth rather than liquidity pressures.
COHR delivered strong top-line growth of 19% to $1.2B while meaningfully expanding R&D investment by 22% to $582M, signaling aggressive investment in innovation. Operating cash flow grew 16% to $634M and capital expenditures increased 27% to $441M, indicating robust reinvestment in the business. The company reduced total debt by 10% to $3.7B while current liabilities jumped 34% to $1.8B, creating a mixed liquidity picture that suggests strong operational activity but requires careful monitoring.
Current liabilities surged 33.6% — significant near-term obligations; verify ability to meet short-term debt.
Capex increased 27.1% — ongoing investment in capacity or infrastructure for future growth.
R&D investment increased 21.5% — signals commitment to future product development, though near-term margin impact.
Revenue growing 19.2% — solid top-line momentum, watch margins for quality of growth.
Operating cash flow grew 16.1% — strong conversion of earnings to cash, healthy business fundamentals.
Receivables grew 13.6% — monitor days sales outstanding for collection efficiency.
Inventory built 11.8% — monitor whether demand supports this build or if write-downs may follow.
Debt reduced 10.1% — deleveraging strengthens balance sheet and reduces financial risk.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →